Correction to: Proteogenomic characterization of molecular and cellular targets for treatment-resistant subtypes in locally advanced cervical cancers (Molecular Cancer, (2025), 24, 1, (77), 10.1186/s12943-025-02256-3)

Correction: Mol Cancer 24, 77 (2025) Following the publication of the original article [1], the authors, during their post-publication review, have noted that the standard acknowledgment required by the International Cancer Proteogenome Consortium (ICPC) was inadvertently omitted. Because the study was conducted under the auspices of ICPC, inclusion of this language is essential for proper attribution and for the consortium’s ongoing efforts to catalogue and promote ICPC-supported research. They therefore respectfully request the publication of an article correction note to address the change in Acknowledgements section. The incorrect and correct Acknowledgements are provided below. Incorrect Acknowledgements: This work was supported by grants from the Proteogenomic Research Project of National Cancer Center, Korea (NCC-1810861, NCC-1810862, NCC-1711260, NCC-2210490), the Basic Science Research Program through the National Research Foundation (NRF) funded by the Ministry of Education, Korea. (2018R1D1A1A09084250, 2021R1F1A1052407, RS-2023-00208004, RS-2023-00217571), and the NAVER Corporation (Grant No. 3720230110). This work was also supported by the Korea Basic Science Institute (KBSI) National Research Facilities & Equipment Center (NFEC) grant funded by the Korean government (Ministry of Education) (2019R1A6C1010028) and by the NRF funded by the Korean government (Ministry of Science and ICT) (NRF-2022M3H9A2086450). Correct Acknowledgements: This work was supported by grants from the Proteogenomic Research Project of National Cancer Center, Korea (NCC-1810861, NCC-1810862, NCC-1711260, NCC-2210490), the Basic Science Research Program through the National Research Foundation (NRF) funded by the Ministry of Education, Korea (2018R1D1A1A09084250, 2021R1F1A1052407, RS-2023-00208004, RS-2023-00217571), and the NAVER Corporation (Grant No. 3720230110). This work was also supported by the Korea Basic Science Institute (KBSI) National Research Facilities & Equipment Center (NFEC) grant funded by the Korean government (Ministry of Education) (2019R1A6C1010028) and by the NRF funded by the Korean government (Ministry of Science and ICT) (NRF-2022M3H9A2086450). This work was done under the auspices of a Memorandum of Understanding between Korea University and the U.S. National Cancer Institute’s International Cancer Proteogenome Consortium (ICPC). ICPC encourages international cooperation among institutions and nations in proteogenomic cancer research in which proteogenomic datasets are made available to the public. This work was also done in collaboration with the U.S. National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium (CPTAC).